NEWS
Cosette takes aim at Mayne’s pleading in damages case
MELBOURNE: US drug maker Cosette wants to strike out Mayne Pharma’s causation pleading in its… read more
EchoIQ prepares $100m raise to expand AI software ambitions
SYDNEY: EchoIQ, a buzzy medical AI software company improving the detection of structural heart disease,… read more
Telix brain cancer data lifts FDA approval hopes
MELBOURNE: Telix Pharmaceuticals shares are up 2.2 per cent at $16.53 after hitting an eight-month… read more
